Ikarian Capital, LLC United Therapeutics Corp Call Options Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 13, 2022
BUY
$166.16 - $213.96 $16.6 Million - $21.4 Million
100,000 New
100,000 $17.9 Million
Q2 2021

Aug 16, 2021
SELL
$170.47 - $211.93 $17.9 Million - $22.3 Million
-105,000 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$153.94 - $174.85 $5.5 Million - $6.24 Million
35,700 Added 51.52%
105,000 $17.6 Million
Q4 2020

Feb 12, 2021
BUY
$101.87 - $151.79 $7.06 Million - $10.5 Million
69,300 New
69,300 $10.5 Million

Others Institutions Holding UTHR

# of Institutions
676
Shares Held
42.1M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email